Abbott (ABT) Tops Q4 EPS by 11c, Revenues Beat
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $116.64 +2.19%
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $1.03, $0.11 better than the analyst estimate of $0.92. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.62 billion.
GUIDANCE:
Abbott sees FY2023 EPS of $4.30-$4.50, versus the consensus of $4.40.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
